Related Experiment Video
Updated: Apr 5, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Calcium and Sudden Cardiac Death in End-Stage Renal Disease
Esther D Kim1, Rulan S Parekh1,2,3
1Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Insights
Sudden cardiac death (SCD) is a major risk for end-stage renal disease (ESRD) patients. Optimal dialysate calcium concentration during dialysis remains debated due to conflicting effects on mortality and arrhythmias.
Area of Science:
- Nephrology
- Cardiology
- Clinical Medicine
Background:
- Sudden cardiac death (SCD) represents a significant cause of mortality in end-stage renal disease (ESRD) patients.
- Dialysis-related factors, particularly calcium derangements, are implicated in the high incidence of SCD in this population.
- Current guidelines offer conflicting recommendations regarding dialysate calcium levels.
Purpose of the Study:
- To investigate the complex role of dialysate calcium concentrations in sudden cardiac death (SCD) among end-stage renal disease (ESRD) patients.
- To evaluate the impact of varying calcium concentrations on cardiovascular mortality and arrhythmogenic triggers in dialysis patients.
- To address the ongoing debate surrounding optimal dialysate calcium management in ESRD.
Main Methods:
- Review of recent evidence linking dialysis-induced calcium dysregulation to mortality and vascular complications.
- Analysis of studies examining the effects of both high and low dialysate calcium on cardiac electrophysiology (e.g., QT dispersion).
- Evaluation of current KDIGO guidelines concerning dialysate calcium recommendations.
Main Results:
- Dialysis-induced calcium imbalances are associated with increased all-cause and cardiovascular mortality, vascular calcification, and SCD risk.
- High dialysate calcium may exacerbate vascular calcification, while low calcium is linked to arrhythmias via QT interval prolongation.
- The optimal dialysate calcium concentration remains undetermined, highlighting a critical knowledge gap.
Conclusions:
- The management of calcium levels during dialysis for ESRD patients presents a complex challenge with significant implications for sudden cardiac death (SCD) risk.
- Further research is essential to establish evidence-based recommendations for optimal dialysate calcium concentrations.
- Balancing the risks of hypercalcemia and hypocalcemia is crucial for improving outcomes in dialysis patients.
Abstract:
Sudden cardiac death (SCD) accounts for a quarter of all deaths in end-stage renal disease (ESRD) patients. While causative mechanisms of SCD in this high risk population remain poorly defined, interaction of the vulnerable myocardium with dialysis-related arrhythmic triggers is thought to play a major role. Recent evidence suggests that dialysis-induced derangement of calcium concentrations contributes to the increased risk of all-cause and cardiovascular mortality, vascular calcification, and SCD. Current KDIGO guidelines recommend avoiding high dialysate calcium concentrations as a precaution against adverse outcomes of increased calcium burden and vascular calcification. Conversely, low calcium concentration is also implicated in the development of SCD via increased QT dispersion and prolonged QT interval. Consequently, the optimal dialysate calcium concentration in dialysis patients remains debated and further studies are needed to establish the best strategy for managing calcium in dialysis patients.
More Related Videos
Related Concept Videos
Coronary Artery Disease III: Clinical Manifestations
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Skeleton and Calcium Homeostasis
Chronic Kidney Disease III: Interprofessional Care
Cardiac Catheterization I: Pre-Procedure Overview

